APA (7th ed.) Citation

F, M., M, S., H, T., Y, O., JC, T., U, B., . . . J, B. (2024). Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: The ARON-2 study. Cancer immunology, immunotherapy : CII, 73(6), 106. https://doi.org/10.1007/s00262-024-03682-w

Chicago Style (17th ed.) Citation

F, Massari, et al. "Global Real-world Experiences with Pembrolizumab in Advanced urothelial carcinoma After Platinum-based Chemotherapy: The ARON-2 Study." Cancer Immunology, Immunotherapy : CII 73, no. 6 (2024): 106. https://doi.org/10.1007/s00262-024-03682-w.

MLA (9th ed.) Citation

F, Massari, et al. "Global Real-world Experiences with Pembrolizumab in Advanced urothelial carcinoma After Platinum-based Chemotherapy: The ARON-2 Study." Cancer Immunology, Immunotherapy : CII, vol. 73, no. 6, 2024, p. 106, https://doi.org/10.1007/s00262-024-03682-w.